AL
Alumis Inc.
ALMS · NASDAQ
$8.40 -8.70% (-$0.80)
1M -67.06%
Market Cap $1.14B
P/E Ratio -
Div. Yield -
ROE 102.97%
Piotroski F-Score Weak
2/9Valuation
38 /100
Fair P/B 2.52x
P/S 153.83x
EV/EBITDA N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 5,933.45%
Op. margin 6,204.39%
FCF margin 4,755.33%
Quality
0 /100
Poor ROE 102.97%
ROA 78.30%
Asset turnover 0.01x
Debt
100 /100
Low Current ratio 6.74x
Debt/Equity 0.08x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 186.73%
Profitable years 0
Beta -0.67x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ALMS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin Babler
Employees
237
Headquarters
South San Francisco
Nadcházející události
12 LIS
Earnings
Upcoming earnings report